Altruist Biologics, an Innovent Biologics subsidiary and world-class contract development and manufacturing organization ...
The project added a new aseptic processing line, as well as an additional 28,000 sq. ft. of utility mezzanine space, to ...
Key opportunities in the blow-fill-seal (BFS) technology market include rising demand for sterile pharmaceutical packaging, growing biologics and vaccine production, increased preference for ...
The update to EU GMP Annex 1 offers market opportunities in aseptic operations, focusing on compliance with new standards. Key areas include contamination control, cleanroom design, and advanced ...
The Slovenian unit of Swiss drugmaker Novartis said it has opened a new factory for sterile filing of biologics and xRNA medicines into syringes and vials, and sterile packaging in the Slovenian ...
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces today the successful ...
Royal Foodstuffs Ltd IPO 1970 - Get Royal Foodstuffs Ltd open and close date, listing date, price band, IPO lot size, allotment, subscription status, review, key insights, and much more only at Busine ...
Builds Upon Previously Announced $2.66 Million Iowa Incentive Package and Supports Planned Facility InvestmentFarm-to-Formula® Platform Expected ...
Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today announced the relocation of Resilience’s corporate headquarters from San Diego, California ...
Today, Argonaut Manufacturing Services (“Argonaut”), a US-based sterile fill-finish CDMO, and Ensera, a CDMO with facilities ...
Aseptic food manufacturing produces sterile, shelf-stable products. The aseptic packaging market, valued at $71.43 billion in 2024, is projected to reach $179 billion by 2033, with a CAGR of 10.8%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results